⭐️CU OncSoc Conference (Saturday, 27 January)⭐️
We are very excited for our diverse range of interactive workshops.
Register before Sunday, 21 January:
https://t.co/7rf89J5bny
@mary_denholm @adnkingdon @J_Kucharczak@hennomartin @ml4cancer
⭐️CU OncSoc Conference (Saturday, 27 January)⭐️
We are very excited for our 3 keynote speakers.
Register before Sunday, 21 Jan:
https://t.co/7rf89J5bny
Prof Paul Workman @ICR_London@Chemical_probes
Prof Grant Stewart @grantissimus
Prof Axel Behrens @imperialcollege@CR_UK
Dr Raj Jena (@ml4cancer) is a group leader in machine learning and radiomics in the Department of Oncology and an honorary consultant in neuro-oncology at Addenbrooke's Hospital. He leads the AI/ML workstream of the £8.2 million CRUK funded RadNet research programme
⭐️CuOncsoc Conference - (27th January 2024) - WORKSHOP ANNOUNCEMENT 6⭐️
Remember to register for the CuOncSoc 2024 conference using the link below or in our bio!
REGISTRATION:
https://t.co/7rf89J5bny
Last to submit an abstract. Open to students outside Cambridge too. All shortlisted poster and oral presenters get to attend the conference for free!
Submit abstract here:
https://t.co/EoGzLvo1F9
CONFERENCE POSTER & ORAL PRESENTATIONS DEADLINE EXTENDED- if you would like to present your Oncology-related research in our conference, please submit your abstract using the google form
https://t.co/6za4ZnFUPh
NEW Deadline for submission is 15th January 2024!
2 more days to submit an abstract. Open to students outside Cambridge too. All shortlisted poster and oral presenters get to attend the conference for free!
Submit abstract here:
https://t.co/EoGzLvo1F9
CONFERENCE POSTER & ORAL PRESENTATIONS DEADLINE EXTENDED- if you would like to present your Oncology-related research in our conference, please submit your abstract using the google form
https://t.co/6za4ZnFUPh
Deadline for submission is in 2 days (15th January 2024!)
The CRUK Convergence Science Centre is a partnership between @imperialcollege , @ICR_London , and @CR_UK, with a mission to bring together engineering, physical sciences, life sciences and medicine to develop innovative ways to address challenges in cancer research.
⭐️ CU OncSoc Conference - (27 Jan 2024) - Keynote Talk 3⭐️
We are delighted to introduce Prof Axel Behrens, Scientific Director of the @CR_UK Convergence Science Centre, as our final keynote speaker.
REGISTER:
https://t.co/7rf89J5bny
SUBMIT ABSTRACT:
https://t.co/EoGzLvo1F9
As a urological surgeon, Grant has a specific interest in optimising the management of patients with initially localised renal cancer, by the development of early detection and optimal peri-surgical management.
⭐️ CU OncSoc Conference - (27 Jan 2024) - Keynote Talk 2 ⭐️
We are delighted to introduce urological surgeon Prof Grant Stewart (@grantissimus) as our next keynote speaker for the conference.
REGISTER:
https://t.co/7rf89J5bny
SUBMIT ABSTRACT:
https://t.co/EoGzLvo1F9
Grant Stewart is the Professor of Surgical Oncology and Honorary Consultant Urological Surgeon at Addenbrooke's Hospital. He is also the Director of the Academic Clinical Fellow Programme in Cambridge.
@ICR_London@Chemical_probes In addition to his distinguished career in academia, Prof Workman has also spent many years in industry at AstraZeneca and is the scientific founder of multiple biotech companies.
⭐️ CU OncSoc Conference - (27 Jan 2024) - Keynote Talk 1 ⭐️
We are excited to introduce Prof Paul Workman, former Chief Executive of @ICR_London and current Director of @Chemical_probes
REGISTER:
https://t.co/7rf89J5bny
SUBMIT ABSTRACT:
https://t.co/EoGzLvo1F9
@ICR_London@Chemical_probes Prof Workman is renowned for his research in molecularly targeted cancer drugs. Of note, Paul has been instrumental in the discovery of two approved drugs: the EGFR inhibitor gefitinib for lung cancer and the AKT inhibitor capivasertib for breast cancer.